|
Apax Partners Apax Partners is one of the world’s largest private
equity groups dedicated to high performance, entrepreneurial businesses.
The group advises a number of Investment Pools with an accumulated
total of €12 billion. For the Investment Pools we advise in Germany
we are searching investment opportunities in 6 industries: Healthcare
/ Biotechnology, Consumer Goods / Retail, Telecommunication Information
Technology, Media / Entertainment, Financial Services. At the moment
we emphasise on investments in large MBOs/MBIs and in high growth
companies with sales of over DM 100 million. The minimum amount for
an investment is DM 15-20 million, with no maximum limit. In the areas
of Biotechnology and Information Technology (IT) we are also interested
in “small” companies that are still in the start-up stages.
An investment of under DM 15 million is possible in these two industries.
The Apax Partners group, which is structured as a partnership, employs
approximately 180 professionals with offices in Europe, the USA, Israel
and Japan. The truly international group was founded by Alan Patricof
more than 25 years ago. |
|
Atlas Venture GmbH Founded in Europe in 1980, Atlas Venture is a truly international venture capital firm, currently managing more than $2.5 billion in committed capital, and making investments from a single fund across geographies and sectors. Atlas Venture is the leading international, early-stage venture capital firm investing in IT, communications, and life sciences companies. Our offices are strategically placed to support our portfolio companies and are split evenly between the United States and Europe. Our Portfolio: Atlas Venture is the nexus of
an active global portfolio network of more than 150 technology companies
and we encourage our portfolio companies to support one another.
Each company benefits not only from our in-house expertise and contacts,
but also from the skills, insight and contacts of other portfolio
companies. Our network, along with our firm’s ties to the leading
technology centers world-wide, gives Atlas Venture portfolio companies
an advantage in anticipating market trends, seizing opportunities
and building partnerships for mutual success. |
 |
|
Carlyle Europe Venture Partners The next generation internet, we believe, will lead to unprecedented value creation opportunities. Bandwidth expansion, everywhere connectivity, flexible networks, distributed and ubiquitous intelligence, and the inter-connectivity of devices will alter the face of communications as we know it. The Carlyle Europe Venture Partners [CEVP] is one of
the largest venture capital funds focused on Europe. Europe will
experience unprecedented opportunities. The UK and the continent
are already beginning to enjoy the benefits of regulatory liberalization,
the emergence of common standards and the growth and mobility of
capital. |
|
Cambridge Antibody Technology Cambridge Antibody Technology (CAT) is a world leading company in the discovery and development of human monoclonal antibody therapeutics. Using its pioneering technologies, CAT has developed an impressive pipeline of novel human monoclonal antibody drugs. Five of these are currently in clinical trials, with the most advanced (D2E7) in Phase III for the treatment of rheumatoid arthritis. The Company's business is driven from a proprietary platform of phage display technologies and extensive phage antibody libraries, which form the basis of the Company’s strategy to develop a portfolio of antibody-based drugs and to untilise antibodies as tools for target validation. To maximise commercial opportunities, CAT has built an array of strategic collaborations with leading pharmaceutical and biotechnology companies worldwide. CAT was established in 1990 and listed on the London Stock Exchange in 1997. In June 2001, CAT completed a listing on the US NASDAQ National Market. Based near Cambridge, UK, the Company currently employs around 250 staff. |
|
E.ON Venture Partners GmbH E.ON Venture Partners is the new Venture Capital (“VC”) arm of the E.ON group. It focuses on early stage investments in young, highly innovative companies mainly in the energy sector. By founding E.ON Venture Partners GmbH early this year E.ON has taken a new approach to corporate venture capital. The approach combines the advantages of typical financial VCs and corporate VCs including brand, network, expertise and business connections of one of the worlds leading business group. E.ON Venture Partners is designed to be a lean, performance-oriented,
and highly flexible organization. Its philosophy is to demand a
lot from start-ups we finance but giving them the best available
support as coach and “sparring-partner” in return. E.ON
Venture Partners is aiming to become the VC “of first choice”
in the energy sector in Europe. |
|
EXTOREL Private Equity Advisors GmbH EXTOREL is one of the leading German management companies for Fund of Funds in the Private Equity industry. The investment programmes are especially tailored for different investor groups like wealthy individuals or institutional investors. The team of EXTOREL has long lasting experience not only in the investment in Venture Capital Funds but also in direct private equity investments. EXTOREL acts also as family office for its main share holder and has about 500 million Euros under management. |
|
Giza Venture Capital Giza Venture Capital is a prominent Israeli venture
capital management company with offices in Tel Aviv, San Francisco,
and Singapore. Active since 1992, Giza has over $250 million under
management. Giza invests in Israeli-related technology companies
in the fields of Communications, Internet-enabling Technology, Software,
and Healthcare. Among the major investors in Giza’s funds are
GE Capital, Deutsche Banc Alex.Brown, and NIB Capital of the Netherlands.
Representative portfolio investments include Precise Software Solutions
(Nasdaq: PRSE), M-Systems (Nasdaq: FLSH), Compugen (Nasdaq: CGEN),
Zoran (Nasdaq: ZRAN), Oridion Systems (traded on SWX New Market
in Switzerland), Libit Signal Processing (acquired by Texas Instruments),
Telegate (acquired by Terayon), and MoreCom (acquired by Liberate
Technologies) . |
 |
|
HBM BioVentures AG / HBM Partners AG HBM Bioventures AG is a Swiss investment company with a capital of more than CHF 500 million. The company invests primarily in later-stage private equity, but also in public companies in the biotechnology, emerging pharmaceutical, medical technology and related industries. HBM BioVentures AG was initiated by Dr. Henri B. Meier, former CFO and current member of the Board of Directors of the Roche Group. HBM Partners AG is the manager of HBM Bioventures AG. HBM Partners has, under the leadership of Dr. Andreas Wicki, assembled a team of experienced professionals, mostly with a background in the pharmaceutical and biotechnology industries. |
|
Intel Capital Europe Intel Capital, Intel's strategic investment program began in the early 1990s and initially invested in PC- and chip-related technologies. Today, Intel Capital invests in companies to establish innovative technologies, help develop industry standards, drive Internet growth, and advance computing platforms in support of Intel's strategic interests. One of the largest corporate venture investing programs in the technology sector, Intel Capital's investment portfolio includes more than 500 technology and related companies worldwide and is valued at approximately US$2.0 billion. The program typically takes small, minority stakes - generally less than US$10 million. Intel Capital also oversees the acquisition of companies that help Intel enter new business areas or that can strengthen existing Intel businesses. Intel's worldwide presence enables Intel Capital to engage with and invest in companies around the world who are developing leading-edge technology. This also helps Intel understand the evolving usage patterns and requirements of technology across many different cultures and languages. Intel has investments in future memory types such as Polymer memories, in MEMs and in additional next generation silicon products. |
|
Israel Seed Partners Israel Seed Partners manage four early stage venture capital funds providing capital to fast growing Israeli technology companies focused on Internet Infrastructure and Communications. Israel Seed leads seed and first rounds where added value in marketing, management, and finance is required to fully develop a company’s potential. Israel Seed is funded by major institutions such as AOL, IBM, MIT, UBS Capital, Horsley Bridge, Axa, DeutscheBank, Wellcome Trust, Invesco, Clal, Flag Ventures a group of leading internet entrepreneurs have also backed Israel Seed Partners including Mark Andreesen, Jerry Yang founder of Netscape and Pierre Omidyar founder of eBay. |
|
Katan Associates International Katan Associates International is a globally based advisory services organization that provides a variety of integrated and interdisciplinary business and financial services to developing, knowledge-based growth and biotechnology companies. Our clients share in the diversified operational, financial and strategic experiences that Katan’s senior management has gained in their various roles with numerous companies. Katan has a proven track record of adding significant value to
formative-stage companies, providing management, financial, business
development and strategic basis for a company’s growth and
success.
|
|
LGT Capital Partners AG LGT Capital Partners is one of Europe’s leading private equity and hedge fund investors and fund of funds managers, with over EUR 1.8bn in private equity assets and over EUR 800m in hedge funds on a global basis. LGT Capital Partners acts both as principal investor and investment manager, with clients investing alongside the team’s own capital. This guarantees a perfect alignment of client's and team's interests. As a principal investor, LGT Capital Partners’ primary objective is to achieve superior risk-adjusted returns by accessing and actively investing in the most promising private equity and hedge fund investment opportunities worldwide. Among other vehicles, LGT Capital Partners’ dedicated team of over 35 alternative investment professionals (with 14 nationalities represented) is responsible for the investment management of two investment companies both listed on the SWX Swiss Exchange and on the Luxembourg stock exchange since 1997: Castle Private Equity and Castle Alternative Invest. LGT Capital Partners’ list of clients includes Axa, Swiss Life, McKinsey & Company, the Princely family of Liechtenstein, and other sophisticated institutional and private investors in Germany and Austria. LGT Capital Partners works with clients as partners, sharing insights and ideas from principal to principal. Over the years, the team has built substantial expertise and an extensive network in the global private equity and hedge fund industries, and is known as a sophisticated, long-term investor with an outstanding track record. LGT Capital Partners AG is operating as an autonomous legal entity in Switzerland. For more information: aim@lgt.com or telephone: +41 55 415 9 415 |
|
Novartis Pharma AG Novartis (NYSE: NVS) is a world leader in healthcare with core businesses in pharmaceuticals, consumer health, generics, eye-care, and animal health. In 2000, the Group’s ongoing businesses achieved collective sales of CHF 29.1 billion (USD 17.2 billion) and a net income of CHF 6.5 billion (USD 3.9 billion). The Group invested approximately CHF 4.0 billion (USD 2.4 billion) in R&D. Headquartered in Basel, Switzerland, Novartis employs about 70 000 people and operates in over 140 countries around the world. For further information please consult http://www.novartis.com. |
|
Pitango Venture Capital Pitango Venture Capital is a leading venture capital firm (Formerly Polaris Venture Capital originated in Israel). To date, the firm has provided value-added investing to more than 80 high-tech companies in Israel, in the fields of communications, software & Internet infrastructure, medical devices and biotechnology. Many Pitango portfolio companies have gone public in the United States and Europe, including ITXC, AudioCodes, BackWeb, Radware, and VocalTec. Pitango operates as the lead investor in seed, early, and expansion-stage companies, and takes an active role in each company's Board of Directors. The firm currently manages four venture funds with over $700 million under management. Pitango is operating through its offices in the Silicon Valley, London and Tel Aviv. |
|
Shell Internet Ventures Shell Internet Ventures (“SIV”) was set up by the Royal Dutch/Shell Group in early 2001 to invest in companies in technologies of relevance to Shell’s present and future operations. The $200 million fund is targeting such areas as: B2B services, software, mobile and wireless businesses, logistics, supply chain management, etc.. The fund investments will be in the $2-10m range in Europe and North America. SIV invests as a returns-driven venture capital fund, not as a strategic investor. It invests to sell, not hold,companies. The fund’s management team, based in London and Houston, will help investee companies to develop commercial linkages to Shell for mutual benefit. |
|
Siemens Mobile Acceleration Siemens Mobile Acceleration enables worldwide the most innovative
and attractive Mobile Business proposals to achieve a rapid market
entry and an international market presence. Our focus is on business
concepts concerned with mobile technologies and wireless applications
and services. We are involved as a shareholder in these companies
and as such provide a uniquely comprehensive service portfolio as
well as financial investments. We promote start-ups both from within
Siemens and from the open market. Our declared objective is to become
one of the leading global players in starting up companies focused
on wireless technologies. Siemens Mobile Acceleration is a wholly-owned
subsidiary of Siemens AG. It is part of the Siemens Mobile Group
and its vision "Innovating the mobile world". |
|
Sofinnova Partners Sofinnova Partners is one of the leading French and European venture capital firms focusing on start-up and early stage companies in both information technologies and life sciences. Initiated in 1972, it has contributed significantly to the emergence and growth of equity financing in France through its leadership position. The Sofinnova Partners team is based in Paris and consists of 8 partners, managing 550 million euros. In April 2001, Sofinnova Partners announced the closure of its last fund, Sofinnova Capital IV, at 330 million euros. The fund will be invested 50% in France, 35% in other European countries and 15% in the US. Since 1996, Sofinnova Partners has made 60 investments, including 34 as lead investor. It currently sits on the boards of 32 companies and continues to provide active support. For more information, please visit www.sofinnova.fr |
|
St John’s Innovation Centre Ltd St John’s Innovation Centre Ltd (SJIC) was established, by St John’s College Cambridge in 1987. The mission of the company is to maximise the College’s return on its investment on the 90,000 sq ft lettable space which comprises the Innovation Centre and to provide an environment, in which early stage businesses particularly in software, IT, scientific instrumentation and biotechnology flourish. SJIC provides services at three levels:-
|
|
T-Venture Of the EUR 400 million of capital currently available, 80 per cent is earmarked for direct investment, and 20 per cent indirectly via VC funds. Each direct investment is in the region of EUR 0.5 to 5 million (although larger amounts are possible), and – as a matter of policy – all investments are minority interests. The preferred financing stages are seed money, start-up financing and expansion financing. Direct investments in suitable companies are undertaken by subsidiaries of the holding company , and managed by “professional” in-house investment managers of which there are currently twenty-two. In parallel, T-Venture also has equity interests in domestic and international VC funds with external venture managers who undertake investments in growth companies and offer T-Venture opportunities for co-investment. In terms of geographical spread, most of the investments are in Europe and the USA. where T-Venture is represented by its own subsidiary (T-Venture of America, Inc) T-Venture has offices in Berlin, Darmstadt, Munich, Boston (MA, USA), Redwood City (CA, USA), Tokyo and Singapore. The present T-Venture portfolio (with an investment cost of approx (EUR 160 m) currently includes 48 businesses (as at December 31, 2000) plus 10 fund holdings. Eight IPO flotations and a successful “trade sale” enabled the portfolio’s value to be tripled within a short period of time. www.telekom.de |
|
Viventures Partners Viventures Partners, a global management company for venture capital which recently closed its second fund with 638 million euros, invests in early stage companies focused on the information technology and telecommunication sectors, primarily on telecom & datacom infrastructures, applications and middleware for telecom (mobile and fixed), and optical components and systems. Viventures invests on a global basis, with at least 50% dedicated to Europe, offering companies not only financial commitment but also the technology, business and international expertise of its experienced partners as well as an extensive worldwide network of resources, including relationships with its global, blue chip investors. In most cases, we invest in the early institutional rounds of funding. In all cases we work very closely with our Limited Partners to forge close business relationships with our portfolio companies. These Limited Partners include over 30 industrial and financial enterprises from Europe, the US and Asia who are global leaders in their respective businesses (technology, telecommunications, media and entertainment, and financial services). This unique mix of investors, present and active on an international scale, reflects the fund's global character and contributes to the long-term financial and business success of the fund's portfolio companies. Viventures Partners is headquartered in Paris, France and has offices in the UK (Reading), the US (San Francisco), Asia (Singapore) and in Sweden (Stockholm) through CGT Equity Advisors, independent advisors to Viventures Partners for the Nordic Region. |
|
Warburg Pincus E. M. Warburg Pincus & Co., LLC (“Warburg Pincus”) is a major global private equity investment firm. Over the past 30 years, it has invested in more than 400 companies worldwide. It is currently managing $10 billion of investments, with a further $4 billion available for investment.. |